Showing results (51-60 of 281) with videos related to
Sort By:
Pageof 29
Cell and Tissue Kinetics|January 1, 1977
Nucleic acid content of HeLa S3 cells during the cell cycle: variations between cyclesW G Thilly, D I Arkin, G N WoganIARC Scientific Publications|January 1, 1996
Use of carcinogen-DNA and carcinogen-protein adduct biomarkers for cohort selection and as modifiable end points in chemoprevention trialsT W Kensler, J D Groopman, G N WoganChemical Research in Toxicology|September 1, 1994
Peracylation of nucleosides with methionine: foundation for a method to detect carcinogen adductsF Z Sheabar, M L Morningstar, G N WoganJournal of Toxicology and Environmental Health|December 1, 1977
Rapid and accurate determination of the median lethal dose (LD50) and its error with a small computerA P Rosiello, J M Essignmann, G N WoganCancer Letters|May 25, 1995
Tissue distribution of DNA adducts in pre-weanling BLU:Ha mice treated with a tumorigenic dose of fluorantheneJ S Wang, W F Busby, G N WoganToxicology and Applied Pharmacology|May 1, 1990
Comparative tissue distribution and excretion of orally administered [3H]diacetoxyscirpenol (anguidine) in rats and miceJ S Wang, W F Busby, G N WoganProceedings of the National Academy of Sciences of the United States of America|January 1, 1990
TPR-MET oncogenic rearrangement: detection by polymerase chain reaction amplification of the transcript and expression in human tumor cell linesN R Soman, G N Wogan, J S RhimChemical Research in Toxicology|June 20, 1998
Mutations induced in the supF gene of pSP189 by hydroxyl radical and singlet oxygen: relevance to peroxynitrite mutagenesisJ K Jeong, M J Juedes, G N WoganCarcinogenesis|November 1, 1995
Formation and persistence of DNA adducts in organs of CD-1 mice treated with a tumorigenic dose of fluorantheneJ S Wang, W F Busby, G N WoganProceedings of the National Academy of Sciences of the United States of America|March 1, 1994
Adduct detection by acylation with [35S]methionine: analysis of DNA adducts of 4-aminobiphenylF Z Sheabar, M L Morningstar, G N WoganPageof 29